A short washout period from fingolimod to anti-CD20 therapy is safe and decreases the risk of reactivation
| Autor: | Gassama, S., Garmendia, A., Lejeune, F.X., Boudot de la Motte, M., Louapre, C., Papeix, C., Maillart, E., Roux, T. |
|---|---|
| Zdroj: | In Revue Neurologique November 2023 179(9):1035-1038 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect